CC
ATXS

Corton Capital’s Astria Therapeutics ATXS Stock Holding History

Corton Capital’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$156K Buy
+21,369
New +$145K 0.38% 141
2025
Q2 		– Sell
-13,534
Closed -$72.3K – 341
2025
Q1 		$72.3K Buy
+13,534
New +$94.7K 0.24% 149
2024
Q4 		– Sell
-20,492
Closed -$226K – 399
2024
Q3 		$226K Sell
20,492
-1,799
-8% -$20K 0.11% 318
2024
Q2 		$203K Buy
+22,291
New +$218K 0.11% 367
2022
Q2 		– Sell
-11,597
Closed -$78K – 337
2022
Q1 		$78K Buy
+11,597
New +$69.1K 0.03% 397

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Corton Capital's ATXS Position: Q3 2025 in Review

Corton Capital opened a new position in Astria Therapeutics (ATXS) in Q3 2025: 21,369 shares worth $156K. The stake represents 0.38% of the portfolio and ranks #141 among its holdings. This is a return to the name: Corton Capital previously reported a position in ATXS as recently as Q1 2025.

Corton Capital first reported a position in ATXS in Q1 2022 and has held it in 5 quarters since. The position peaked at $226K in Q3 2024. 115 funds tracked by Wall St. Rank hold ATXS as of Q3 2025.

  • Corton Capital held 21,369 shares of Astria Therapeutics worth $156K as of Q3 2025.
  • Astria Therapeutics was a new Corton Capital position in Q3 2025.
  • Astria Therapeutics made up 0.38% of Corton Capital's portfolio in Q3 2025, its #141 holding.
  • Corton Capital first reported a position in Astria Therapeutics in Q1 2022 and has held it in 5 quarters since.
  • Corton Capital's Astria Therapeutics position peaked at $226K in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Astria Therapeutics as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.